Becton Dickinson and Co (BDX)
7 Mar 2014
|Market Cap (Mil.):||$22,307.46|
|Shares Outstanding (Mil.):||193.02|
NEW YORK, Dec 17 - Biodel Inc : * Up 10.5 percent premarket after supply agreement with Becton Dickinson for liquid glucagon rescue device
- Medical technology company Becton Dickinson & Co said on Tuesday that quarterly net income fell as costs rose sharply, but after excluding litigation charges and pension settlements, the results were higher than analysts had expected.
Nov 5 - Medical technology company Becton Dickinson & Co said on Tuesday that quarterly net income fell as costs rose sharply, but after excluding litigation charges and pension settlements, the results were higher than analysts had expected.
Sept 20 - Becton Dickinson and Co said it may have to pay up to $340 million after a federal jury found the medical device maker guilty of attempting to monopolize the safety syringe market through deceptive practices.
|Baxter International Inc. (BAX.N)||$67.50||-0.07|
|Covidien plc (COV.N)||$71.35||-0.10|
|Stryker Corporation (SYK.N)||$81.64||+0.69|
|Boston Scientific Corporation (BSX.N)||$13.70||+0.15|
|C.R. Bard, Inc. (BCR.N)||$143.71||0.00|
|Hologic, Inc. (HOLX.OQ)||$22.53||+0.55|
|Quidel Corporation (QDEL.OQ)||$29.14||+0.24|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (BDX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Pechala's Reports
Becton Dickinson and Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC